Repetitive Bleomycin-Based Electrochemotherapy Improves Antitumor Effectiveness in 3D Tumor Models of Conjunctival Melanoma
Journal of Clinical Medicine · 30.01.2023 · 12 (3) · 1087
DOI: 10.3390/jcm12031087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.01.2023. Verfasst von Joana Heinzelmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Halle-Wittenberg, 06120 Halle, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Rolf M. Schwiete Stiftung, Rolf M. Schwiete Stiftung.
Abstract (Originalsprache)
Background
Conjunctival melanoma (CM) is associated with a high rate of local recurrence and poor survival rate. Novel therapeutic options are needed to reduce recurrence rate. The objective of the study was to demonstrate the improved effectiveness of electrochemotherapy (ECT) on CM using repetitive application.
Methods
Tumor spheroids of three CM cell lines (CRMM1, CRMM2, CM2005.1) were treated repetitively with ECT using the chemotherapeutic agent bleomycin on days 3, 5, and 7 of culture. Application of bleomycin alone and electroporation alone served as controls. The cytotoxic effect was analyzed on day 10 compared to untreated control using an independent t-test. The spheroid outgrowth rate was measured.
Result
CM tumor spheroid size (median value: 78%, SD: 32%) and viability (median value: 11%, SD: 11%) were dramatically reduced after repetitive ECT treatment (p-value < 0.001). Decreased proliferation capacity (down to 8%) and an increase of apoptotic cells were observed. In most repetitive ECT-treated spheroids, no viable or proliferating cells were detected. Only 33–40% of repetitive ECT-treated spheroids exhibited single outgrowing cells with a delay of time up to 38 days.
Conclusion
Repetitive ECT application effectively induces cytotoxic effects in CM spheroids by inducing apoptosis, inhibiting proliferation and decreasing the percentage of surviving tumor cells. Thus, repetitive ECT results in improved antitumor effectiveness in CM and could be an alternative therapy option.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Halle-Wittenberg, 06120 Halle, Germany.
- Institute of Pathology, University Hospital Halle-Wittenberg, 06112 Halle, Germany.
- Institute of Pathology, University Hospital Köln, 50996 Köln, Germany.
ORCID-Profile: Joana Heinzelmann
Förderung
- Dr. Rolf M. Schwiete Stiftung
- Rolf M. Schwiete Stiftung
Zitieren
APA
Heinzelmann, J., Hecht, S., Vogt, A. R., Siebolts, U., Kaatzsch, P., & Viestenz, A. (2023). Repetitive Bleomycin-Based Electrochemotherapy Improves Antitumor Effectiveness in 3D Tumor Models of Conjunctival Melanoma. Journal of Clinical Medicine, 12(3), 1087. https://doi.org/10.3390/jcm12031087
Vancouver
Heinzelmann J, Hecht S, Vogt AR, Siebolts U, Kaatzsch P, Viestenz A. Repetitive Bleomycin-Based Electrochemotherapy Improves Antitumor Effectiveness in 3D Tumor Models of Conjunctival Melanoma. Journal of Clinical Medicine. 2023;12(3):1087. doi:10.3390/jcm12031087
BibTeX
@article{Heinzelmann2023,
author = {Heinzelmann, Joana and Hecht, Sabine and Vogt, Alexander Ruben and Siebolts, Udo and Kaatzsch, Peter and Viestenz, Arne},
title = {Repetitive Bleomycin-Based Electrochemotherapy Improves Antitumor Effectiveness in 3D Tumor Models of Conjunctival Melanoma},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {3},
pages = {1087},
doi = {10.3390/jcm12031087}
}
EUVIMED